Low-oxygen activated joint chloroethane nitrourea compound and preparation method and application

A compound and composition technology, applied in the field of pharmacy, can solve the problems of non-targeting, increased toxicity and side effects of chemotherapy drugs, and enhanced damage to normal cells, etc.

Active Publication Date: 2016-04-20
BEIJING UNIV OF TECH
View PDF1 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the study found that due to O 6 - The inhibition of AGT by benzylguanine is not targeted, and in combination with alkylating agents, O 6 - Benzylguanine inhibits the AGT activity in tumor cells, but also acts on normal cells, resulting in the inhibition of AGT activity in normal cells, thereby destroying the normal cell's DNA damage repair mechanism and increasing the DNA damage of normal cells , leading to increased toxic an

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Low-oxygen activated joint chloroethane nitrourea compound and preparation method and application
  • Low-oxygen activated joint chloroethane nitrourea compound and preparation method and application
  • Low-oxygen activated joint chloroethane nitrourea compound and preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0061] Example 1: N-(2-chloroethyl)-N’-3-(O 6 -Benzyl-N 2 -(((4-nitrobenzyl)oxy)carbonyl)9-guaninyl)ethyl-N-nitrosourea (compound 1)

[0062] 1)N9-Bromoethyl-O 6 -Synthesis of benzylguanine

[0063] Weigh O 6 -Benzylguanine (0.96g, 4mmol), anhydrous potassium carbonate (1.66g, 12mmol) were added to a three-necked flask, 100mL acetone was added, the temperature was slowly raised to 50℃, and 1,2-dibromoethane (1.4 mL, 16mmol), continue to react for 60h after the completion of dripping, filter the reaction solution, collect the filtrate, and then spin dry the solvent under reduced pressure at 40°C, and then separate and purify by silica gel column chromatography. The eluent is petroleum ether and ethyl acetate. Gradient elution, the volume ratio of petroleum ether / ethyl acetate gradually increased from 1:2 to 1:4, and dried under vacuum at 40°C to obtain white solid N9-bromoethyl-O 6 -Benzylguanine (1.11g, 3.2mmol), yield 80%.

[0064] UVλ: 250,283nm. IR(KBr tablet)v / cm -1 :3468.6(N-(...

Example Embodiment

[0080] Example 2: N-(2-chloroethyl)-N’-3-(O 6 -Benzyl-N 2 -(((4-nitrobenzyl)oxy)carbonyl)9-guaninyl)propyl-N-nitrosourea (compound 2) synthesis

[0081] 1)N9-Bromopropyl-O 6 -Synthesis of benzylguanine

[0082] Weigh O 6 -Benzylguanine (1.44g, 6mmol), anhydrous potassium carbonate (3.32g, 24mmol) were added to a three-necked flask, 150mL acetone was added, the temperature was slowly raised to 55℃, and 1,3 dibromopropane (3.03mL, 30mmol), continue to react for 65h after dripping, filter the reaction solution, collect the filtrate, and distill under reduced pressure at 40°C to remove the solvent, and then separate and purify by silica gel column chromatography. The eluent is petroleum ether and ethyl acetate, and gradient elution is adopted. , The volume ratio of petroleum ether / ethyl acetate gradually increased from 1:2 to 1:4, vacuum dried at 40°C to obtain white solid N9-bromopropyl-O 6 -Benzylguanine (1.59g, 4.4mmol), yield 73%.

[0083] UVλ: 250,284nm. IR(KBr tablet)v / cm -1 :345...

Example Embodiment

[0099] Example 3: N-(2-chloroethyl)-N’-3-(O 6 -Benzyl-N 2 Synthesis of -(((4-nitrobenzyl)oxy)carbonyl)9-guaninyl)butyl-N-nitrosourea (compound 3)

[0100] 1)N9-Bromobutyl-O 6 -Synthesis of benzylguanine

[0101] Weigh O 6 -Benzylguanine (0.72g, 3mmol), anhydrous potassium carbonate (1.66g, 12mmol) were added to a three-necked flask, 80mL acetone was added, the temperature was slowly raised to 55℃, and 1,4 dibromobutane (1.8mL) , 15mmol), continue the reaction for 70h after the completion of dripping, filter the reaction solution, collect the filtrate, after the solvent is distilled off under reduced pressure at 40°C, it is separated and purified by silica gel column chromatography. The eluent is petroleum ether and ethyl acetate. After removing, the volume ratio of petroleum ether / ethyl acetate gradually increased from 1:2 to 1:4, and dried under vacuum at 40°C to obtain white solid N9-bromobutyl-O 6 -Benzylguanine (0.79g, 2.1mmol), yield 70%.

[0102] UVλ: 250,284nm. IR(KBr tablet...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a compound with a formula (II) structure or a pharmaceutically accepted salt. The formula (II) structure is shown in the attached figure. The compound with the formula II structure has good targeting property and tumor cell killing capability, and can be used for preparing targeting tumor chemotherapy drugs. The compound has the advantages that on one hand, chloroethene-based carbon positive ions can be decomposed in vitro, the crosslinking with DNA (deoxyribonucleic acid) is caused, and the function of inhibiting the growth of tumor cells is realized; on the other hand, an O6-benzylguanine similar drug effect group is selectively released in cancer cells under the low-oxygen condition, the function of inhibiting the AGT (angiotensinogen) activity of the tumor cells is realized in a targeting way, and the drug resistance of the tumor cells to nitrosourea drugs is decreased.

Description

technical field [0001] The invention relates to the technical field of pharmacy, in particular to hypoxic activation combined with chloroethylnitrosourea compounds, a preparation method and application. Background technique [0002] Chloroethylnitrosoureas (CENUs) are an important class of bifunctional antitumor alkylating agents, which are widely used in clinical practice. As shown in the structure of compound Ⅰ, clinically representative CENUs drugs mainly include carmustine (BCNU), semustine (Me-CCNU), nimustine (ACNU), and lomustine (CCNU). . CENUs are broad-spectrum antitumor drugs, which are clinically used in the treatment of brain tumors, myeloma, malignant melanoma, malignant lymphoma, lung cancer, breast cancer, gastric cancer and leukemia. Because CENUs easily cross the blood-brain barrier, its concentration in the cerebrospinal fluid can reach 30-35% of the plasma concentration, so it has a good curative effect especially on brain tumors. CENUs play an antican...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D473/18A61K31/522A61P35/00A61P35/02
CPCA61K9/0019A61K9/0053A61K9/08A61K9/2059A61K9/4866A61K47/02A61K47/26C07D473/18
Inventor 赵丽娇彭瑞增任婷张淑芬钟儒刚
Owner BEIJING UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap